Article
Innovation in oncology treatments has reduced the mortality rate for cancer, but it comes at a price. At the 5th Annual Patient-Centered Oncology Care, experts will discuss cost-sharing models, as well as updates in cancer care treatment, such as precision medicine and immuno-oncology.
Innovation in oncology treatments has reduced the mortality rate for cancer, but it comes at a price. Specifically, the cost of medications. The price of treatment has steadily risen over the years to $100,000 a year and more. At the 5th Annual Patient-Centered Oncology Care, to be held in Baltimore, Maryland, November 17-18, experts will discuss cost-sharing models, as well as updates in cancer care treatment, such as precision medicine and immuno-oncology.
The meeting will bring together providers, payers, and leaders from oncology policy, academia, quality measurement, patient education, advocacy, and pharmaceutical manufacturing.
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.